Indie Asset Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,841
Closed -$305K 89
2025
Q1
$305K Sell
1,841
-244
-12% -$38.2K 0.26% 65
2024
Q4
$302K Buy
2,085
+79
+4% +$12.2K 0.24% 72
2024
Q3
$325K Buy
2,006
+36
+2% +$5.74K 0.24% 67
2024
Q2
$288K Sell
1,970
-608
-24% -$90.4K 0.23% 71
2024
Q1
$408K Buy
2,578
+22
+0.9% +$3.5K 0.36% 44
2023
Q4
$401K Hold
2,556
0.36% 40
2023
Q3
$398K Buy
2,556
+18
+0.7% +$2.97K 0.4% 40
2023
Q2
$420K Buy
2,538
+1
+0% +$161 0.46% 36
2023
Q1
$393K Hold
2,537
0.46% 40
2022
Q4
$448K Hold
2,537
0.49% 41
2022
Q3
$414K Sell
2,537
-200
-7% -$33.8K 0.42% 43
2022
Q2
$486K Sell
2,737
-100
-4% -$17.8K 0.43% 39
2022
Q1
$503K Buy
2,837
+15
+0.5% +$2.55K 0.38% 48
2021
Q4
$483K Sell
2,822
-1,612
-36% -$264K 0.35% 55
2021
Q3
$716K Buy
4,434
+1,456
+49% +$248K 0.58% 33
2021
Q2
$491K Sell
2,978
-321
-10% -$53.1K 0.4% 54
2021
Q1
$542K Sell
3,299
-47
-1% -$7.61K 0.62% 45
2020
Q4
$527K Sell
3,346
-2,211
-40% -$326K 0.61% 42
2020
Q3
$827K Buy
5,557
+30
+0.5% +$4.44K 1.04% 23
2020
Q2
$818K Sell
5,527
-50
-0.9% -$7.29K 1.03% 23
2020
Q1
$731K Sell
5,577
-375
-6% -$53.2K 0.91% 25
2019
Q4
$868K Buy
+5,952
New +$807K 0.92% 24

Other funds holding JNJ

Indie Asset Partners's JNJ Position: Q2 2025 in Review

Indie Asset Partners sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,841 shares — an estimated $305K sold.

Indie Asset Partners first reported a position in JNJ in Q4 2019 and held it in 22 quarters. The position peaked at $868K in Q4 2019. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Indie Asset Partners reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Indie Asset Partners sold 1,841 Johnson & Johnson shares in Q2 2025, an estimated $305K.
  • Indie Asset Partners first reported a position in Johnson & Johnson in Q4 2019 and held it in 22 quarters.
  • Indie Asset Partners's Johnson & Johnson position peaked at $868K in Q4 2019.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Indie Asset Partners's 13F filing for Q2 2025, filed 12 Aug 2025.